The mTOR You Know podcast

Resident Blog - Gillian Steiger

0:00
11:42
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

PGY2 SOT Gillian Stiger joins us from the Hospital of the University of Pennsylvania to discuss “Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study”, as well as a discussion on her residency experience with belatacept rapid conversion for a patient with thrombotic microangiopathy associated with tacrolimus.

Fler avsnitt från "The mTOR You Know"